網頁設計公司 hong kong 相關
廣告上個月有 超過 1 萬 名用戶曾瀏覽 tw.strikingly.com
支持自定義表單,域名,設計,線上商城,網誌,在線支付等功能。實時客服,輕鬆構建你想要的網站。 支持自訂表單、域名、設計,線上商城、部落格、金流等功能。實時客服,輕鬆構建你想要的網站。
可加入各種功能例如購物,招收會員,影片播放等等. 20多年經驗專業設計各類網站, 私人或商業網站均可
上個月有 超過 100 萬 名用戶曾瀏覽 booking.com
住宿预订遍及全球150,000个目的地。Booking.com官方网站。
Design Your Dream Site with Wix's Professional Templates & Intuitive Customization. Design a Website You're Proud of With Wix's Powerful, Integrated Tools. Start Now!
搜尋結果
Search drug, interactions and image information in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia, India & USA.
Search company information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.
Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company.
- Rm 30-101, 30/F, The Gateway Tower 515 Canton RdTsim Sha TsuiHong Kong
- 2881 5811
Hong Kong Poison Classification. Poison Classification for Hong Kong. Non-poison (NP) May be sold by medicine retailers. Part II poisons (P2) May be sold within the registered premises of an Authorised Seller of Poisons (ASP), commonly known as pharmacy or dispensary, or a Listed Seller of Poisons. Part 1 only Poisons (P1)
IPSEN PHARMA (HONG KONG) c/o DCH Auriga (Hong Kong) Ltd - Healthcare Division. Headquartered in France, Ipsen is a European pharmaceutical group which currently markets over 20 medicinal products throughout the world, mainly in Europe.
- Room 42, 47 & 48, 34/F, Tower OneTimes Square, 1 Matheson StreetCauseway BayHong Kong
- 2637 8898
Tagrisso FC tab 40 mg. Packing/Price. 30's. Form. Tagrisso FC tab 80 mg. Packing/Price. 30's. Tagrisso (Osimertinib mesylate): Adjuvant treatment after complete tumour resection in adults w/ stage IB-IIIA NSCLC whose tumours have epidermal growth fac.
Dosage/Direction for Use. SC Initially 0.25 mg once wkly. After 4 wk, increase dose to 0.5 mg once wkly. After at least 4 wk w/ 0.5 mg once wkly, dose can be increased to 1 mg once wkly to further improve glycaemic control. Click to view Ozempic detailed prescribing information.